Nuclear Medicine: Page 276

DOPA-PET/CT can alter therapy for neuroendocrine tumors

By Wayne Forrest

Swiss researchers have found that combined fluorine-18 dihydroxyphenylalanine (F-18 DOPA) contrast-enhanced PET/CT is "significantly superior" to DOPA-PET and contrast-enhanced CT in detecting neuroendocrine tumors.

January 14, 2010

FDG-PET distinguishes Parkinson's from other disorders

By Wayne Forrest

With the help of FDG-PET, researchers in New York have developed an automated image-based classification procedure to differentiate patients with idiopathic Parkinson's disease from those with other brain diseases such as multiple system atrophy and progressive supranuclear palsy.

January 10, 2010

PET/CT finds brain-disorder-related cancer other modalities miss

By Wayne Forrest

In patents with suspected paraneoplastic neurological disorders, PET/CT is "very helpful" in detecting cancer as the cause of the condition when other imaging modalities and clinical exams find no evidence of cancer, according to an article published online January 11 in the Archives of Neurology.

January 10, 2010

AuntMinnie.com Molecular Imaging Insider

By Wayne Forrest

January 10, 2010

MDS finalizes CEO position

By AuntMinnie.com staff writers

MDS, parent company of MDS Nordion, finalized its executive restructuring January 8 by appointing Steve West as its CEO.

January 7, 2010

AECL requests uranium from U.S.

By AuntMinnie.com staff writers

Atomic Energy of Canada (AECL) last month requested 16.3 kg of high-enriched uranium (HEU) that it may need to resume production of medical isotopes once its National Research Universal nuclear reactor in Chalk River, Ontario, is repaired.

January 6, 2010

International Isotopes files permit with NRC

By AuntMinnie.com staff writers

Radioisotope manufacturer International Isotopes has submitted a license application to the U.S. Nuclear Regulatory Commission (NRC) to build a uranium deconversion and fluorine extraction processing plant on a 640-acre site west of Hobbs, NM.

January 4, 2010

PET plays key role in Parkinson's research

By Wayne Forrest

A four-year study to measure the effectiveness of dopamine cell transplantation in Parkinson's disease patients indicates it produces significant improvements in motor skills and brain function, according to the January issue of the Journal of Nuclear Medicine.

January 4, 2010

GE licenses molecular radiotracers

By AuntMinnie.com staff writers

GE Healthcare has licensed technology related to molecular radiopharmaceuticals from the Medical College of Wisconsin in Milwaukee.

December 28, 2009

Nuclear physicians lose ground in thyroid; top 10 stories of the decade

By Brian Casey

December 28, 2009

Study shows budding turf war for radioiodine procedures

By Wayne Forrest

A new study indicates that endocrinologists are handling more therapeutic radioiodine procedures for hyperthyroidism and thyroid cancer, taking more of that duty from nuclear medicine physicians and radiologists. A change in physician certification rules could be to blame for the shift, researchers say.

December 28, 2009

Second PET scan can spot seizure origin in epilepsy patients

By Wayne Forrest

Researchers at the Cleveland Clinic in Ohio say physicians should consider a second FDG-PET scan to help localize seizure origin in patients with refractory epilepsy whose initial images show regional hypermetabolism.

December 28, 2009

Previous Page

Page 276 of 440

Next Page